Docusign raised its fiscal 2027 guidance for revenue, annual recurring revenue and Intelligent Agreement Management’s share of ARR after reporting second-quarter results. The setup is constructive for DOCU, but the available figures do not show how much of the raise is flowing through to growth or profitability.
Docusign raised its fiscal 2027 guidance for revenue, annual recurring revenue and Intelligent Agreement Management’s share of ARR after reporting second-quarter results.
The guidance raise moves the operating read higher for DOCU, with the trade still dependent on the size of the revenue and ARR uplift and its effect on margins.
The setup weakens if the detailed release shows only a modest guidance increase, weaker profitability than the 79.4% gross margin and 9.6% net margin profile, or limited conversion of IAM adoption into ARR.
CoverageFirst reported by PR Newswire at 4:05 PM ET · the only report so farHow this is decided →
PR NEWSWIRE / FILEDocusign said it had reported financial results for the second fiscal quarter ended July 31, 2026, and increased its fiscal 2027 outlook for revenue, annual recurring revenue and the percentage of ARR generated by Intelligent Agreement Management. The announcement was issued on Sept. 3, 2026, through PR Newswire, with prepared remarks and the full release made available alongside the results.
The guidance change is the key new element in the release. Docusign’s latest reported fiscal-year profile, for the year ended Jan. 31, 2026, showed revenue of $3.2B, up 8.2% YoY. The company also reported a 79.4% gross margin, a 9.6% net margin and $1.48 in diluted EPS in that filing.
The revenue and ARR guidance updates speak directly to Docusign’s subscription business, while the IAM update points to a shift in product mix. Intelligent Agreement Management is being measured as a percentage of total ARR, tying adoption of that offering to the recurring-revenue base rather than treating it solely as a new-product narrative. The release does not provide the size of the new fiscal 2027 targets in the supplied material.
The evidence is positive but incomplete. The announcement confirms that management raised multiple operating measures, yet it does not specify the revised revenue, ARR or IAM percentages, nor does it identify the quarter’s reported revenue, margins or earnings in the available summary. That leaves open how much of the improved outlook reflects durable demand, product conversion or assumptions about execution later in the fiscal year.
The next useful checkpoints are Docusign’s detailed second-quarter filing and prepared remarks, followed by the company’s next earnings release. Those materials should establish the magnitude of the guidance increase, the contribution from IAM, and whether the 79.4% gross-margin and 9.6% net-margin profile is holding as the product mix changes. They should also clarify whether the $1.48 diluted-EPS base is translating into stronger forward earnings visibility.
The constructive signal is the simultaneous increase in fiscal 2027 revenue, ARR and IAM-mix guidance, which strengthens the growth narrative against DOCU’s existing $3.2B revenue base and 8.2% YoY growth. The supplied release does not give the revised targets or second-quarter margin and earnings detail, so the read stays non-directional until the size and quality of the raise can be assessed.
The read above, as written. kept as written
Into the next earnings print. Follow to be told when one lands.
The strongest bull case is that higher fiscal 2027 revenue and ARR guidance, alongside a larger IAM percentage of total ARR, marks a credible acceleration from the prior 8.2% YoY growth rate.
The bear case is that the announcement supplies no revised targets or quarterly profitability figures, leaving the guidance raise too unquantified to establish durable earnings upside from the $1.48 diluted-EPS base.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →